Researchers report a new drug can help to reduce symptoms of cannabis withdrawal for those with cannabis use disorder.
A new study reveals how dangerous inflammations in the brain are caused during the aging process. Researchers say failure with the CB1 to control activity of immune cells may result in chronic neuroinflammation. They say it may be possible to break this vicious cycle in the future with drugs that contain THC, which is a powerful CB1 receptor activator.
Using optogenetics, researchers have identified a causal association between dopamine and avoidance behavior linked to pain and fear.
Researchers reveal drinking four to eight cups of coffee a day decreases neurotransmitters related to the endocannabinoid system. The study also reports caffeine increases metabolites in the androsteriod system.
Researchers discover the FABP5 protein is key to how endocannibinoids travel from neurons to receptors.
Vanderbilt researchers have mapped a signaling system in the brain that appears to be linked to autism.
A new study in PNAS reveals how the body converts omega 3 fatty acids into endocannabinoids, which can have anti-inflammatory effects.
Researchers report deficiencies of natural cannabinoids could result in a predisposition for developing depression and PTSD. Boosting the system could help in treating stress related disorders.
According to researchers, cannabinoids can reduce cravings and help ease withdrawal for those addicted to opioids.
A new study suggests developing new therapeutics that use cannabinoid receptors to treat chronic pain.
While marijuana can initially help with symptoms of anxiety and depression, it can be detrimental to mental health when used long term, a new study reports.
Researchers have created the most detailed 3D structure to date of the brain receptor that binds and responds to the root of the marijuana high.
